What did @socalurologyinstitute actually say?
The creator explained HCG as a compound that mimics luteinizing hormone (LH), the pituitary signal that tells testicles to produce testosterone and sperm. They outlined three main use cases: supporting fertility when sperm quality is poor, co-administering with testosterone to prevent testicular atrophy and maintain endogenous production, and helping men restart natural testosterone production after anabolic steroid or long-term TRT use. The framing is clinical and concise, avoiding the kind of hype you'd expect from a hashtag like #testosteronebooster.
Notably missing: any discussion of HCG's regulatory status, which matters a lot right now. The FDA reclassified HCG as a biologic in 2020, which effectively ended the era of compounded HCG for most purposes. That context would have made this video meaningfully more useful to the 117,000 people who watched it.
Does the science back this up?
Yes, the core pharmacology is accurate. HCG binds to LH receptors on Leydig cells in the testes, stimulating intratesticular testosterone production and supporting spermatogenesis. The mechanism is well-established and not seriously contested.
On fertility: a 2013 Cochrane review (Attia et al., Cochrane Database of Systematic Reviews) found that gonadotropin therapy including HCG improved sperm parameters in men with hypogonadotropic hypogonadism, though evidence in broader populations is thinner. On testicular atrophy during TRT: Hsieh et al. (2013, Journal of Urology) found that adjunctive HCG at 500 IU every other day maintained intratesticular testosterone and testicular volume in men on exogenous testosterone. That directly supports what the creator said about "the best of both worlds." On post-anabolic steroid recovery: HCG is a standard component of post-cycle therapy protocols, though randomized trial data on outcomes is limited compared to the widespread clinical use.
What did they get wrong (or right)?
Mostly right on the science, but there is a meaningful omission that affects real patients watching this video.
The creator says HCG "stimulates the testicles to make more testosterone, more sperm." That is accurate for men with hypogonadotropic hypogonadism or those suppressed by exogenous androgens. But HCG does not reliably boost testosterone or sperm in men with primary testicular failure (hypergonadotropic hypogonadism), where the problem is the testicles themselves, not the signal. That distinction matters clinically and was not made here.
The claim that "testosterone slows down the body's production of testosterone" is accurate, a reference to the hypothalamic-pituitary-gonadal (HPG) axis suppression, but calling it a slowdown undersells it. Exogenous testosterone can suppress endogenous production to near zero in many men (Bhasin et al., 2001, NEJM). "Slows down" is soft language for what is often complete suppression.
What they got right: the three clinical indications described (fertility, co-administration with TRT, post-cycle recovery) reflect actual prescribing patterns and are supported by published literature. No overclaiming, no miracle language. That is more than most TRT content on this platform manages.
What should you actually know?
HCG is not freely available the way it used to be. In 2020, the FDA determined that HCG qualifies as a biologic under the Biologics Price Competition and Innovation Act, which effectively ended routine compounding of HCG for most indications. Patients who were on compounded HCG for TRT adjunct therapy had to transition to alternatives.
The main alternative now used in many TRT protocols is kisspeptin/FSH support or, more commonly, gonadorelin, a GnRH analog that stimulates the pituitary rather than acting directly on the testes. Clomiphene citrate is another option for men trying to maintain fertility or natural production. None of these were mentioned in the video, which was recorded without apparent acknowledgment of the regulatory shift.
If you are watching this video and thinking about adding HCG to a TRT protocol, the first conversation to have is not about mechanism, it is about what is actually accessible and legal in your region and what the prescribing physician is working with. Telehealth platforms operating under state and federal guidelines have specific constraints here that matter for your safety and continuity of care.
- HCG works by mimicking LH, not by being LH. The distinction matters for receptor binding and downstream effects.
- Post-cycle recovery with HCG is common practice but the evidence base for long-term outcomes is weaker than for fertility indications.
- Not all causes of low testosterone respond to HCG. Primary hypogonadism will not.